LOGIN
Heterotopic ossification prophylaxis with etoricoxib versus diclofenac after THA
June 2016
Heterotopic ossification prophylaxis with etoricoxib versus diclofenac after THA
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac
Int Orthop. 2016 Apr;40(4):673-80Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
100 patients scheduled for total hip arthroplasty were randomized to one of two different oral non-steroid anti-inflammatory drugs (NSAIDs) for heterotopic ossification (HO) prophylaxis; etoricoxib or diclofenac. Patients were assessed over a 6 -month follow-up for the development of HO. Results demonstrated no significant differences between groups in the development of HO. No patient of either g...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.